Urology and Gynecology: Trends in Medical Devices
A Survey of Fifty-five Urologists
Study Description
|
Respondent Type |
Physicians |
|
Specialties Covered |
Urology & Gynecology |
|
Region |
United States Only |
|
Methodology |
Online, self-administered survey Approximately ten to 30 minutes duration, dependent upon specialty Fifty-five total respondents Fielded online from May 7 to May 10, 2007 |
Objectives
Assess recent trends in medical device usage and pricing in urology and gynecology for the following conditions: urinary incontinence (male and female), uterine/vaginal prolapse, uterine health and permanent sterilization, obstructive and non-obstructive benign prostatic hyperplasia, and erectile dysfunction. Additionally;
§ Identify usage patterns of medical devices in urology and gynecology
§ Determine recent trends in pricing and reimbursement
§ Clarify drivers of usage for each physician specialty
§ Compare devices in each category based on a set of attributes
§ Assess the potential for future usage of these devices
§ Identify new and promising treatments for these conditions
Companies and Products Mentioned in This Report
|
Company |
Ticker Symbol |
Product(s) |
|
American Medical Systems Holdings Inc. |
AMMD |
AMS Dura II Malleable 650/600M |
|
Ethicon/Johnson & Johnson |
JNJ |
The Indigo Laser System |
|
Medtronic Inc. |
MDT |
Prostiva TUNA |
|
Urologix Inc. |
ULGX |
Targis TUMT |
|
AMS |
|
Greenlight TherMatrx Ambicor 2-piece & 700 MS Tactile Pump |
Inclusion Criteria and Respondent Demographics
|
Inclusion Criteria
|
§ US-based board certified or eligible urologists, gynecologists & prostate/colorectal surgeons § Two to 30 years of experience post-residency § Spends at least 50% of professional time in clinical practice § Performs at least one specified procedure type per month, on average |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |